An Update on Seasonal and Pandemic Influenza Readiness and Treatment CME

Ronald F. Grossman, MD, FCCP, Chair; Elizabeth L. Daugherty, MD; Andrew T. Pavia, MD; Robert A. Weinstein, MD Author Information and Disclosures

Release Date: January 11, 2008; Valid for credit through January 11, 2009

Credits Available
Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians

The content of this CME activity, "An Update on Seasonal and Pandemic Influenza Readiness and Treatment", was developed by the faculty.

To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. Overview of EpidemiologyRobert A. Weinstein, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
  2. Infection Control and Quarantine IssuesElizabeth L. Daugherty, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
  3. Update on Treatment of InfluenzaAndrew T. Pavia, MDAvailable As: Slides/Audio | Slides/Transcript | Audio
  4. Alternative Modes of Ventilation During a Pandemic Epidemic -- Pros and ConsRonald F. Grossman, MD, FCCPAvailable As: Slides/Audio | Slides/Transcript | Audio
  5. Question and Answer SessionFacultyAvailable As: Slides/Audio | Slides/Transcript | Audio

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 CHEST
Gilead
Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Assess risks for influenza in specific patient populations.
  2. Describe the processes necessary to care for patients with influenza.
  3. Prepare strategies based on guidelines and expert recommendations for the therapeutic control of seasonal and pandemic influenza.
Author Disclosures

Ronald F. Grossman, MD, FCCP
Disclosure: Consultant/Speakers' Bureau/Advisory Committee/Advisory Board: Bayer, GlaxoSmithKline, Ortho-McNeil, sanofi-aventis, Wyeth


Elizabeth L. Daugherty, MD
Disclosure: Dr Daugherty has nothing to disclose.


Andrew T. Pavia, MD
Disclosure: Dr Pavia has nothing to disclose. Product/procedure/technique that is considered research and is NOT yet approved for any purpose: there are no FDA-approved antivirals for pandemic influenza strains -- all discussion is of research use.


Robert A. Weinstein, MD
Disclosure: Dr Weinstein has nothing to disclose.
 
American College of CHEST Physcians
The American College of Chest Physicians (ACCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.The ACCP takes responsibility for the content, quality, and scientific integrity of the CME activity.

The American College of Chest Physicians designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Anyone who participates on the Medscape website session entitled “Update on Seasonal and Pandemic Influenza Readiness and Treatment” stemming from the CHEST 2007 Satellite, and already claimed CME for this presentation from the live session at CHEST 2007 or the Influenza-info.org site, cannot claim CME from this enduring product.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.